Triptolide是由中草药-雷公藤中提取的免疫抑制剂。
Triptolide inhibits DNA-dependent ATPase activity of XBP and induces inhibition of RNA polymerase II (RNAPII)-mediated transcription (IC50 = 200 nM). Blocks RNA synthesis in HeLa cells (IC50 = 62 nM); exhibits potent antiproliferative activity in 60 cancer cell lines (average IC50 = 12 nM) and induces apoptosis by blocking TNF-α-mediated c-IAP1 and c-IAP2 induction. Triptolide has been shown to induce apoptosis of T lymphocytes by activating caspases, displaying an increase of DEVD-cleavable caspase activity correlated with the apoptosis. The proliferation of rheumatoid synovial fibroblasts characteristic of rheumatoid arthritis was similarly suppressed by treatment with Triptolide through an increase in caspase-3 activity. Cytokine gene expression in blood lymphocytes and T-cells are also suppressed by Triptolide, blocking the transcriptional activation of purine-box/antigen receptor response element/nuclear factor of activated T-cells (NF-AT) and of NF-kappaB. Also displays immunosuppressive and anti-inflammatory activity.
Cells
MCF-7 cells were were cultured in phenolred-free medium.
AntiproliferativeActivity
Antiproliferative activity was determined usingthe colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide(MTT) method. Cells were grown on tissue culture flasks in Dulbecco’s ModifiedEagle’s Medium (DMEM) containing 10% heat-inactivated fetal bovine serum (FBS) andantibiotics (100 U/ml penicillin G, 100μg/mlstreptomycin) at 378C in 5% CO2 and 95% air in a humidified incubator.At the start of the experiment, the cell suspension at a density of 1 3 105 wastransferred to 96-well microplates (180μl/well).After 24 h of cell culture, the medium was replaced by 10% dextrancharcoal(DCC) treated FBS which containing 10, 50, and 100 nM triptolide, 1 nM of E2alone or the combination of triptolide and E2 for 24, 48, and 72 h,respectively. At the end of treatment period, 20 mL of MTT reagent (5 mg/ml inPBS) was added to each well. The plates were then incubated for 4 h at 37oCin the dark. The medium was removed and MTT reduction product (formazancrystals) was dissolved in Dimethyl Sulfoxide (DMSO), and the absorbance at 570nm was measured with an ELISA reader.
Xenograft tumor model
Six-week-old NOD.CB17 Prkdcscid/J mice weremaintained in a microisolator in pathogen-free conditions. The mice weredivided into four groups; each mouse in each group (n = 5; 5-FU, n = 3) wassubcutaneously injected with 2 × 106 of both SAS and SAS coculturedwith macrophage-like U937 cells. Three days later, the mice in each group werefurther treated with triptolide (TPL) (0.15 mg/kg/day) and 5-FU (12 mg/kg/day),and a vehicle control (PBS) was then separately administered to the groupsthrough intraperitoneal (ip) injection. The size of the transplanted tumors wasmeasured using gauged calipers twice a week, and the tumor volume wascalculated using the following formula: volume (V) = 1/2 × (length × width2).At the end of the treatment, the mice were sacrificed, and the tumors wereremoved, weighed, and photographed.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Qiu, D., et al. 1999. J. Biol. Chem. 274: 13443-13450.
[2] Kusunoki, N., et al. 2004. BMC Pharmacol. 4 :2.
[3] Liacini, A., et al. 2005. Biochem. Biophys. Res. Commun. 327: 320-327.
分子式 C20H24O6 |
分子量 360.4 |
CAS号 38748-32-2 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 30 mg/mL |
Water <1 mg/mL |
Ethanol 1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02115659 | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Drug: Triptolide-Containing Formulation|Drug: Placebo | Shanghai Changzheng Hospital | Phase 3 | 2014-04-01 | 2014-04-16 |
NCT01817283 | HIV | Drug: Triptolide|Drug: cART|Drug: placebo | LI Taisheng|Peking Union Medical College | Phase 1|Phase 2 | 2013-01-01 | 2013-03-22 |
NCT00801268 | Polycystic Kidney | Drug: tripterygium wilfordii|Drug: Emodin | Zhi-Hong Liu, M.D.|Nanjing University School of Medicine | 2008-11-01 | 2015-03-27 | |
NCT02002286 | HIV | Drug: Tripterygium Wilfordii Hook F extract (TwHF extract)|Drug: cART | LI Taisheng|Peking Union Medical College | 2011-08-01 | 2013-11-29 | |
NCT02044952 | Inflammatory Bowel Diseases|Crohn's Disease|Gastrointestinal Diseases|Digestive System Diseases|Intestinal Diseases | Drug: Mesalazine, Tripterygium glycosides | Zhu Weiming|Jinling Hospital, China | Phase 2|Phase 3 | 2014-01-01 | 2014-01-22 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们